Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(13 sites) United States
Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton, Fullerton, California Baptist MD Anderson Cancer Institute, Jacksonville, Florida Saint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health Care, Edgewood, Kentucky HealthPartners Frauenshuh Cancer Center, Saint Louis Park, Minnesota HealthPartners Cancer Center at Regions Hospital, Saint Paul, Minnesota NYU Long Island Mineola, Mineola, New York Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York White Plains Hospital Center for Cancer Care - Oncology, White Plains, New York Utah Cancer Specialists, Salt Lake City, Utah UVA Emily Couric Cancer Center, Charlottesville, Virginia Virginia Cancer Specialists, Fairfax, Virginia Virginia Mason Franciscan Health - Virginia Mason Medical Center, Seattle, Washington Japan
The University of Tokyo Hospital, Bunkyo-ku, Tokyo